Front Cover   Mission   Cambrex Overview   2003 Financial Highlights   To Our Shareholders   Human Health   Bioproducts   Biopharma   Corporate Information   Glossary   FORM 10-K   + PART I     + ITEM 1 BUSINESS.     + ITEM 2 PROPERTIES.     + ITEM 3 LEGAL PROCEEDINGS.     + ITEM 4 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.   + PART II     + ITEM 5 MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.     + ITEM 6 SELECTED FINANCIAL DATA.     + ITEM 7 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.     + ITEM 8 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.       + REPORT OF INDEPENDENT AUDITORS       + CONSOLIDATED BALANCE SHEETS       + CONSOLIDATED INCOME STATEMENTS       + CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY       + CONSOLIDATED STATEMENTS OF CASH FLOWS       + NOTES TO CONSOLIDATED FINANCIAL STATEMENTS         + (1) THE COMPANY         + (2) RESTATEMENT OF FINANCIAL RESULTS         + (3) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES         + (4) ACQUISITIONS         + (5) GOODWILL AND INTANGIBLE ASSETS         + (6) IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS         + (7) NET INVENTORIES         + (8) PROPERTY, PLANT AND EQUIPMENT         + (9) ACCRUED LIABILITIES         + (10) INCOME TAXES         + (11) SHORT-TERM DEBT         + (12) LONG-TERM DEBT         + (13) DERIVATIVES AND FAIR VALUE OF FINANCIAL INSTRUMENTS         + (14) DISCONTINUED OPERATIONS -- SALE OF RUTHERFORD CHEMICALS         + (15) STOCKHOLDERS' EQUITY         + (16) STOCK OPTIONS         + (17) RETIREMENT PLANS         + (18) OTHER POSTRETIREMENT BENEFITS         + (19) RESTRUCTURING, IMPAIRMENTS AND OTHER CHARGES         + (20) OTHER INCOME AND EXPENSE         + (21) SEGMENT INFORMATION         + (22) FOREIGN OPERATIONS AND EXPORT SALES         + (23) COMMITMENTS         + (24) CONTINGENCIES       + SELECTED QUARTERLY FINANCIAL DATA     + ITEM 9 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.     + ITEM 9A CONTROLS AND PROCEDURES.   + PART III     + ITEM 10 DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.     + ITEM 11 EXECUTIVE COMPENSATION.     + ITEM 12 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.     + ITEM 13 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.     + ITEM 14 PRINCIPAL ACCOUNTING FEES AND SERVICES.   + PART IV     + ITEM 15 EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K.   + SIGNATURES   + EXHIBIT INDEX     + REVISED SCHEDULE OF PARTIES     + 2001 PERFORMANCE STOCK OPTION PLAN     + 2003 PERFORMANCE STOCK OPTION PLAN     + SUBSIDIARIES OF REGISTRANT     + CONSENT OF INDEPENDENT ACCOUNTANTS     + POWER OF ATTORNEY     + CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002     + CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   Back Cover